Therapeutic indications: Zoladex is indicated: • In the treatment of metastatic prostate cancer where Zoladex has demonstrated comparable survival benefits to surgical castrations • In the treatment of locally advanced prostate cancer, as an alternative to surgical castration where Zoladex has demonstrated comparable survival benefits to an anti-androgen • As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer where Zoladex has demonstrated improved disease-free survival and overall surviva • As neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer where Zoladex has demonstrated improved disease-free survival • As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression where Zoladex has demonstrated improved disease-free survival (see section 5.1)
Features
Nature and contents of container • Zoladex LA is supplied as a single dose SafeSystem™ syringe applicator with a protective sleeve in a sealed pouch which contains a desiccant.
Special precautions for storage • Do not store above 25°C.
Patient Information Leaflet https://www.medicines.org.uk/emc/files/pil.1567.pdf
Therapeutic indications: Zoladex is indicated: • In the treatment of metastatic prostate cancer where Zoladex has demonstrated comparable survival benefits to surgical castrations • In the treatment of locally advanced prostate cancer, as an alternative to surgical castration where Zoladex has demonstrated comparable survival benefits to an anti-androgen • As adjuvant treatment to radiotherapy in patients with high-risk localised or locally advanced prostate cancer where Zoladex has demonstrated improved disease-free survival and overall surviva • As neo-adjuvant treatment prior to radiotherapy in patients with high-risk localised or locally advanced prostate cancer where Zoladex has demonstrated improved disease-free survival • As adjuvant treatment to radical prostatectomy in patients with locally advanced prostate cancer at high risk of disease progression where Zoladex has demonstrated improved disease-free survival (see section 5.1)
Features
Nature and contents of container • Zoladex LA is supplied as a single dose SafeSystem™ syringe applicator with a protective sleeve in a sealed pouch which contains a desiccant.
Special precautions for storage • Do not store above 25°C.
Patient Information Leaflet https://www.medicines.org.uk/emc/files/pil.1567.pdf